Posted on 10/1/20
Johnson & Johnson Acquires Momenta Pharmaceuticals for $6.5B
Johnson & Johnson (NYSE: JNJ) today announced it has successfully completed its acquisition of Momenta Pharmaceuticals, Inc., a company that discovers and develops novel
Posted on 10/1/20
DiamiR Awarded $3.86M in Two Grants from the NIH
DiamiR, a developer of innovative blood-based diagnostic solutions for brain health and other indications, announced today that the National Institute on Aging (NIA) of the National . . .
Posted on 10/1/20
Fairmount Partners Advises INVIVO Communications in Sale to Red Nucleus
Red Nucleus, a premier provider of learning, performance, and process solutions for the life sciences industry, announced that it has acquired INVIVO Communications, a leading digital . . .
Posted on 10/1/20
Why Celldex Has Been A Big Winner In 2020
SummaryCelldex stock rose sharply after CDX-0159 data was announced in June.CDX-527 Phase 1 trial is now underway.Top line CD-3379 Phase 2 data should arrive before year-end.Celldex . . .
Posted on 10/1/20
Better Buy: GlaxoSmithKline vs. Pfizer
Have all of the stocks of drugmakers in the coronavirus vaccine race delivered solid gains so far this year? Nope. GlaxoSmithKline's (NYSE:GSK) adjuvant is being used . . .
Posted on 9/30/20
Interview with Ted Quinn, CEO & Founder of Activate Care
Ted Quinn is the CEO and Co-founder of Activate Care, a digital health company helping everybody engaged in
Posted on 9/30/20
PMV Pharma Closes $243.5M IPO
CRANBURY, N.J., Sept. 29, 2020 (GLOBE NEWSWIRE) -- PMV Pharmaceuticals, Inc., a precision oncology company pioneering the discovery and development of small molecule, tumor-agnostic therapies targeting . . .
Posted on 9/29/20
FlowMetric Life Sciences and Penn State University Collaborates
FlowMetric Life Sciences, Inc., a global leader in immunology testing services, and the Huck Institutes of the Life Sciences at Penn State University announce the creation . . .
Posted on 9/29/20
Otsuka America Pharmaceutical Earns Designation as a Great Place to Work-Certified Company In 2020
PRINCETON, N.J. & ROCKVILLE, Md.--(BUSINESS WIRE)--Otsuka America Pharmaceutical, Inc., (Otsuka) today announced that it is Great Place to Work-Certified. Certification is a significant achievement. Using validated . . .
Posted on 9/29/20
Aclipse Therapeutics Awarded AUD 1 Million Grant from FightMND
RADNOR, Pa.--(BUSINESS WIRE)--Aclipse Therapeutics, a private Pennsylvania biopharmaceutical company, was awarded an AUD 1 million (approximately US $720,000) drug development research grant from FightMND, the largest . . .
Posted on 9/29/20
AmerisourceBergen Will Soon Be Rewarded For Quietly Growing Profits
SummaryThe current stock market is still expensive by historical standards, but deals do occasionally appear.AmerisourceBergen's earnings have mostly been unaffected by COVID-19 and continue to grow . . .
Posted on 9/29/20
Inovio Coronavirus Vaccine Candidate Trial Halted Due to FDA Inquiry
Inovio Pharmaceuticals (NASDAQ:INO) stock was really taking it on the chin Monday, following a very discouraging revelation from the company.The biotech announced that morning that the . . .
Posted on 9/28/20
Palatin Technologies Announces Fourth Quarter 2020 Financial Results
Palatin Technologies, Inc. (NYSE American: PTN), a specialized biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin and natriuretic peptide . . .
Posted on 9/28/20
Immunome Aims For $30 Million U.S. IPO
SummaryImmunome has filed proposed terms for a $30 million IPO.The firm is advancing antibody-based treatment candidates for cancer and the Covid-19 virus.IMNM is still at a . . .
Posted on 9/28/20
Is Inovio Worth Buying During the Market Correction?
Inovio Pharmaceuticals (NASDAQ:INO) has been one of 2020's hottest coronavirus vaccine stocks. At one point, it was trading 10 times higher than it began the year, . . .
Posted on 9/28/20
If You Invested $1,000 in Inovio Pharmaceuticals in January, This Is How Much You'd Have Now
Investors who owned Inovio Pharmaceuticals (NASDAQ:INO) and held the stock through the year have been well rewarded for taking a position in the high-risk, high-reward biotech.A . . .
Posted on 9/27/20
PMV Pharma Prices IPO
CRANBURY, N.J., Sept. 24, 2020 (GLOBE NEWSWIRE) -- PMV Pharmaceuticals, Inc., a precision oncology company pioneering the discovery and development of small molecule, tumor-agnostic therapies targeting . . .
Posted on 9/25/20
For Investors, Is Owning Johnson & Johnson Stock a Vice or a Virtue?
Warren Buffett is quoted as saying, "It takes 20 years to build a reputation and only five minutes to ruin it." When I was a graduating . . .
Posted on 9/23/20
Johnson & Johnson Initiates Pivotal Global Phase 3 Clinical Trial of Janssen's COVID-19 Vaccine Candidate
Johnson & Johnson (NYSE: JNJ) (the Company) today announced the launch of its large-scale, pivotal, multi-country Phase 3 trial (ENSEMBLE) for its COVID-19 vaccine candidate, JNJ-78436735, . . .
Posted on 9/23/20
Why Pfizer's Latest Big Win Makes It an Even Better Buy for Retirees
When you're retired, your investing priorities change. You're less likely to look for the hottest growth stock around. Instead, stocks with steady dividends that could still . . .
Posted on 9/22/20
PHOENIX Rehabilitation & Health Services Launches New Brand Identity As Phoenix Physical Therapy
Physical therapy leader PHOENIX Rehabilitation & Health Services, Inc. has completed its transition to a new brand identity as Phoenix Physical Therapy, to align with the . . .
Posted on 9/22/20
Marinus Announces One-for-Four Reverse Stock Split
RADNOR, Pa.--(BUSINESS WIRE)--Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat rare seizure disorders, today announced that it . . .
Posted on 9/22/20
PMV Pharmaceuticals Seeks $125 Million To Enter Trials
SummaryPMV Pharmaceuticals has filed proposed terms for its U.S. IPO plan.The firm is developing treatments for various cancers.PMVP just received approval to enter Phase 1 trials . . .
Posted on 9/21/20
Integral Molecular Awarded Grant from the Commonwealth of Pennsylvania
Integral Molecular has been awarded $521,723 from the Commonwealth of Pennsylvania to leverage its technologies in the global fight against COVID-19. Integral Molecular is at the . . .
Posted on 9/22/20
Henry Mortimer, citybiz Editor-at-Large, Interview with Mark Olcott, CEO of VitusVet
Helping Veterinarians Run Their Practices More Efficiently — and Making Pets Healthier By Henry Mortimer, citybiz Editor-at-Large Any breakdown in communication can jeopardize the important relationship between . . .
Philadelphia
